Abstract
Bioinformatics is a set of enabling technologies responsible for the annotation, storage,
analysis and search/retrieval of nucleic acid sequence, protein sequence and structural information.
This includes integration of the information on the sequences and structures of nucleic acids and
proteins into databases such as EMBL, as well as methods to access, search, model and analyze this
information.
This BCC study examines the current status of the worldwide bioinformatics industry and assesses
its growth potential over a six-year period to 2010. Of particular interest is the value added by
bioinformatics in the process of drug discovery and development. Also examined are various
technologies and patenting trends in the industry. In addition, market potential for emerging
bioinformatics applications such as gene therapy, molecular medicine, etc. is assessed.
Primary focus is on the application of bioinformatics to the process of drug discovery and
development, the major user of the technology. Worldwide activity in this sector was considered for
this report.
View Cart
